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Numerous studies have provided suggestive evidence that the loss of plasmids correlates with the loss of
infectivity of the Lyme disease spirochetes. In this study we have further investigated this correlation. Clonal
populations were obtained from the skin of a mouse infected for 3 months with a clonal population of Borrelia
burgdorferi B31MI. The complete plasmid compositions of these populations were determined using a combi-
nation of PCR and Southern hybridization. The infectivities of clones differing in plasmid composition were
tested using the C3H-HeJ murine model for Lyme disease. While several clones were found to be noninfectious,
a correlation between the loss of a specific plasmid and loss of infectivity in the clones analyzed in this report
was not observed. While it is clear from recent studies that the loss of some specific plasmids results in
attenuated virulence, this study demonstrates that additional mechanisms also contribute to the loss of
infectivity.
Infection with pathogenic species of the Borrelia burgdorferi
sensu lato complex can lead to Lyme disease, an infection
characterized by highly variable multisystem clinical manifes-
tations (30, 31). Early studies suggested that plasmid-encoded
proteins play an important role in Borrelia pathogenesis (26,
28), and in recent years it has been demonstrated that they also
play an important role in immune evasion (37, 43). In addition,
several plasmid-borne genes have been demonstrated to be
up-regulated during infection, supporting a functional role for
the proteins in the mammalian environment (1, 11, 39). The
ability to define a correlation between specific plasmids and
infectivity has until recently been complicated by the inherent
instability of the Borrelia plasmids and the variation in plasmid
content among isolates (3, 9, 17, 18, 20, 25, 28, 29, 40, 41). Prior
to the determination of the complete genome sequence and
plasmid content of B. burgdorferi, these features made it diffi-
cult to interpret and compare much of the earlier data. Deter-
mination of the genome sequence of B. burgdorferi B31MI and
other analyses revealed the existence of both linear and circu-
lar comigrating plasmids of between 24 and 56 kb that could
not be distinguished by agarose gel electrophoresis (5, 10, 15,
35). There are also several distinct yet closely related circular
plasmids (designated cp) of approximately 32 kb (cp32) (33,
35) and multiple linear plasmids (designated lp) of approxi-
mately 28 kb (lp28s). The cp32s have extended regions of
homology, while the lp28s have significantly less identity. In
addition to comigrating plasmids, the genome also contains an
extraordinary number of plasmid-carried paralogous gene fam-
ilies (n 5 175). This genetic redundancy, which could allow for
functional complementation of plasmid-encoded proteins,
coupled with the inherent instability of the Borrelia plasmids
has made it difficult to pinpoint one or more specific plasmids
as essential for infectivity (4, 9, 17, 28, 37, 38, 43). However,
two recent independent studies by Labandeira-Rey and Skare
and by Purser and Norris have provided evidence that lp25 and
lp28-1 may be necessary for full virulence (16, 22). These
studies clearly demonstrate that the loss of specific plasmids is
one mechanism by which decreased virulence can occur. It
should also be noted that in a recent study by Siebers et al. (27)
it was demonstrated that clonal variations in pathogenicity
arise after infection and subsequent subsurface plating of the
Lyme disease spirochetes. However, Siebers et al. utilized B.
burgdorferi ZS7, an isolate of undefined genomic composition,
and did not determine the plasmid contents of the clones with
different pathogenicities. Hence, the basis for the loss of in-
fectivity in the clones analyzed was not determined.
In this report, we have continued to assess putative correla-
tions between plasmid content and infectivity and have em-
ployed clonal populations of defined genetic composition to
achieve this goal. By defining the plasmid compositions of a
series of clones derived from an infectious clone of B. burgdor-
feri B31MI and then testing the infectivities of these clones in
C3H-HeJ mice, we demonstrate that loss of infectivity can
occur in isolates that still retain lp25 and lp28-1. While lp25
and lp28-1 appear to be important for infectivity, the data
presented here demonstrate that mechanisms in addition to
the loss of these plasmids can also lead to the loss of infectivity.
MATERIALS AND METHODS
Generation of postinfection isogeneic clones of B. burgdorferi B31MI. All
analyses were conducted using the cloned isolate B. burgdorferi B31MI (kindly
provided by Mark Hanson at MedImmune Inc., Gaithersburg, Md.), designated
the parental clone (pc), and clonal populations derived from it. This isolate was
selected for analysis because the sequence of its entire genome is now available
(http://www.tigr.org) (15). Upon receipt of the isolate, its infectivity was con-
* Corresponding author. Mailing address: Department of Microbi-
ology and Immunology, School of Medicine, Medical College of
Virginia at Virginia Commonwealth University, Richmond, VA 23298-













firmed using the C3H-HeJ murine model for Lyme disease as previously de-
scribed (37). In brief, 103 spirochetes were needle inoculated intradermally
between the shoulder blades of three 6-week-old C3H-HeJ mice. After 4 weeks,
1-mm-diameter ear punch biopsy specimens were collected and placed in BSK-H
complete medium (Sigma) containing antibiotics (phosphomycin, 20 mg ml21;
rifampin, 50 mg ml21; amphotericin, 2.5 mg ml21; Sigma). After the infection was
confirmed, it was allowed to persist for a total of 3 months. At this point, ear
punch biopsy specimens were again collected and placed in medium for cultiva-
tion as described above. The spirochetes were maintained in this medium until
growth became evident as determined by dark-field microscopy and were then
subsurface plated (37). Colonies were evident after approximately 2 weeks, and
well-isolated colonies were selected for analysis. These populations are hence-
forth referred to as postinfection clonal populations.
PCR analyses. PCR analyses were performed using isolated DNA or DNA
released from lysed cells as a template. When lysed cells were used as a template,
1 ml of culture (;2.0 3 108 cells) was pelleted (14,500 3 g; 5 min), and the cells
were resuspended in phosphate-buffered saline (pH 7.4) and enumerated by
dark-field microscopy. The cells were pelleted, resuspended in sterile water (5 3
106 cells/ml), and boiled for 5 min; the cellular debris was removed by centrifu-
gation, and the supernatant was transferred to a new tube for use as the template
in PCR analyses.
PCR was performed using DNA from 5 3 106 cells, 300 to 400 pg of each
primer pair (Table 1), Supermix (Gibco-BRL), and 0.4 U of recombinant Taq in
a reaction volume of 20 ml. The reaction mixtures were overlaid with mineral oil,
and PCR was performed as follows: 1 min at 94°C followed by 35 cycles of 1 min
at 94°C, 1 min at 45°C, and 2 min at 72°C. A final extension step of 72°C for 6 min
was performed. The amplicons were analyzed in 1% agarose gels containing 0.5
mg of ethidium bromide/ml. Positive controls included a low-passage, infectious,
wild-type clonal isolate derived from B31 (MSK5) known to contain most of the
known B. burgdorferi plasmids (16) and B. burgdorferi B31MIpc, for which the
entire plasmid content and genome sequence are known. The absence of specific
plasmids, inferred from a negative PCR result, was confirmed through Southern
hybridization analyses as described below.
Southern hybridization analyses. Isolated genomic DNA from each clonal
population, obtained as previously described (18), was digested with HaeIII
(standard conditions) and fractionated by electrophoresis in 0.8% agarose gels.
The DNA was stained with ethidium bromide and transferred onto Hybond N
membranes by vacuum blotting, using the VacuGene system (Pharmacia) and
protocols provided by the manufacturer. The DNA was fixed to the membrane
by UV irradiation using the Bio-Rad GS Gene Linker. Hybridization conditions,
washes, and oligonucleotide probe labeling were as previously described (6). All
oligonucleotide probes and primers are described in Table 1.
Analysis of the infectivity of B. burgdorferi clones in mice. The infectivities of
B. burgdorferi B31MI clones were tested using the murine model for Lyme
disease infection. The infective potential of B. burgdorferi B31MIpc has been
previously established, and we have experienced a 100% success rate in the
TABLE 1. Probe and primer sequences and target sites
Probe or
primer Sequence (59 to 39) Target site
uhb(1) GTTGGTTAAAATTACATTTGCG Binds within the UHB element (19) of plasmids cp32-3, cp32-9, cp32-6, cp32-5,
cp32-7, cp32-1, cp32-2, and cp32-8
uhb2(1) CTTTGAAATATTGCAATTAT Binds within the UHB element of cp32-9, cp32-4 and cp32-3, cp32-5 and cp32-2
bbc10F GAACTATTTATAATAAAAAGGAGAGC Positions 6742 to 6717 of cp9
bbc10R ATCTTCTTCAAGATATTTTATTATAC Positions 6284 to 6309 of cp9
bbb19F AATAATTCAGGGAAAGATGGG Positions 16960 to 16980 of cp26
bbb19R AGGTTTTTTTGGACTTTCTGCC Position 17511 to 17532 of cp26
lp5F CTTGCTTTAAGCCCTATTTCAC Positions 1921 to 1942 of lp5
lp5R GCACACTACCCATTTTTGAATC Positions 2543 to 2565 of lp5
bbd10F CAAACTTATCAAATAGCTTATG Positions 5935 to 5957 of lp17
bbd10R ACTGCCACCAAGTAATTTAAC Positions 6432 to 6454 of lp17
bbu21F AGTAAAGGAGTTCTGCAAAAATT Positions 15242 to 15264 of lp21
bbu21R GTTGTCACCTCGTGTAATATG Positions 15787 to 15818 of lp21
bbe16F ATGGGTAAAATATTATTTTTTGGG Positions 10163 to 10187 of lp25
bbe16R AAGATTGTATTTTGGCAAAAAATTTTC Positions 9570 to 9594 of lp25
bbf20F ATGAACAAAAAATTTTCTATTTC Positions 10969 to 10991 of lp28-1
bbf20R GTTGCTTTTGCAATATGAATAGG Positions 10701 to 10723 of lp28-1
bbg02F TCCCTAGTTCTAGTATCTACTAGACCG Positions 1116 to 1142 of lp28-2
bbg02R TTTTTTTTGTATGCCAATTGTATAATG Positions 1899 to 1925 of lp28-2
bbh06F GATGTTAGTAGATTAAATCAG Positions 2320 to 2340 of lp28-3
bbh06R TAATAAAGTTTGCTTAATAGC Positions 2950 to 2970 of lp28-3
bbh08 CCTGAGGACCTTTTATGGAGAC Positions 3657 to 3677 of lp28-3
bbi16F AGGCCGGATTTTAATATCGA Positions 7231 to 7253 of lp28-4
bbi16R TTTATATTTTGACACTATAAG Positions 8511 to 8534 of lp28-4
bbk19F AAGTTTATGTTTATTATTGC Positions 12625 to 12644 of lp36
bbk19R ATTGTTAGGTTTTTCTTTTCC Positions 13234 to 13214 of lp36
bbj34F AAATTCTATGGAAGTGATG Positions 26350 to 26332 of lp38
bbj34R TTTATCTTTATTTTTAGGC Positions 25340 to 25358 of lp38
bba16F GCACAAAAGGTGCTGAG Positions 10272 to 10289 of lp54
bba16R TTTTAAAGCGTTTTTAAGC Positions 11111 to 11093 of lp54
bbq47F AAGATTGATGCAACTGGTAAAG Positions 29997 to 30018 of lp56
bbq47R CTGACTGTAACTGATGTATCC Positions 30951 to 30971 of lp56
D645(2) CTCCTATGATAGTTTGACCT Targets the erpD gene on cp32-2
D701(2) CCAAGTTGTACGTATAGAGC Targets the erpD gene on cp32-2
K647(2) TTTCTTTAGCTATATCGCTAG Targets within BBM38 on cp32-6
M527(2) AGTCGTTCTTCTCTTTCTC Targets within BBO40 on cp32-7
bbn39F AATAGAAAGTAGGAATGGTGCCGAAC Positions 26644 to 26669 on cp32-9
bbn39R GTATACGCAAATTTAGTTACACC Positions 27848 to 27870 of cp32-9
C241(2) TGCGAATGTATCAGAGTCTCC Positions 241 to 261 of erpC on cp32-2
PG(1) CCCACGATATCTCTCCCGTAT Targets BBS41 carried on cp32-3
BBL TCCAGATTCTGGACTTTTTTGAA Positions 21501 to 21523 of cp32-8
BBP AATTATGGACGTGGGAATAAA Positions 21557 to 21777 of cp32-1











recovery of spirochetes from experimentally infected C3H-HeJ mice (n 5 30) by
cultivation of ear punch biopsy specimens (37). In the first round of experiments
designed to test for infectivity, an inoculum of ;500 spirochetes was used. In the
second round of experiments, three mice were inoculated with 107 spirochetes
each. Ear punch biopsy specimens were collected at 4 and 12 weeks postinocu-
lation and placed in BSK-H complete medium containing antibiotics. After 12
weeks, the mice were sacrificed and the spleens, kidneys, and blood were col-
lected and placed individually in BSK-H complete medium.
RESULTS
Analysis of the cp32 plasmid family in pre- and postinfec-
tion clonal populations derived from B. burgdorferi B31MIpc.
We began our assessment of a possible correlation between
specific plasmids and infectivity by determining the cp32 plas-
mid compositions of several clonal populations derived from B.
burgdorferi B31MIpc. We initially focused on the cp32a, since
these plasmids carry several gene families suggested to con-
tribute to pathogenicity (21, 32, 36, 37, 42). C3H-HeJ mice
were infected for 3 months, and then postinfection clonal pop-
ulations were collected (n 5 100). The composition of the cp32
plasmid family was determined for several clones by using a
hybridization approach. The preinfection clonal population
was confirmed to harbor seven cp32s (Table 2). All oligonu-
cleotide probes used in this report were designed based on the
B. burgdorferi B31MI genome sequence (9). The uhb(1) oli-
gonucleotide targets a segment of the cp32s that is referred to
as the upstream homology box (UHB) element (19). This con-
served element resides upstream of three different lipoprotein-
encoding gene families (ospE, ospF, and family 163) that are
carried by the cp32s (and lp56) (2, 4, 15, 19, 35, 38). Note that
the designation “family 163” was devised by The Institute for
Genomic Research (15). Using the known cp32 sequences for
B. burgdorferi B31MI, the sizes of HaeIII restriction fragments
derived from each plasmid that carry target sites for each
probe could be deduced (Table 3), thereby allowing the deter-
mination of which cp32s were present or absent. All clones
were found to carry several uhb(1)-hybridizing fragments,
with 7 of 20 clones exhibiting hybridization profiles identical to
that of B. burgdorferi B31MIpc (Fig. 1 shows representative
data). cp32-4 and cp32-3 were present in all clones, while




MSK5 pc c9 c14 c17 c24 c29 c36 c37 c53
Infectivity ND 7/7 0/6 0/6 0/6 0/6 4/4 4/4 4/4 7/7
lp5 (T) 1 1 1/2 2 1/2 1/2 2 1 2 1/2
cp9 (C) 1 1 1/2 2 1/2 1/2 2 2 2 1/2
cp26 (B) 1 1 1 1 1 1 1 1 1 1
lp17 (D) 1 1 1 1 1 1 1 1 1 1
lp21 (U) 1 1 1 1 1 1 1 1 1 1
lp25 (E) 1 1 1/2 1 1 1 1 1 1 1
lp28-1 (F) 1 1 1 1 1 1 1 1 1 1
lp28-2 (G) 1 1 1 1 1 1/2 2 2 1 1
lp28-3 (H) 1 1 2 2 2 2 2 2 2 2
lp28-4 (I) 1 1 1 1 1 1 1/2 1 1 1
lp36 (K) 1 1 1 1 1 1 1 1 1 1
lp38 (J) 1 1 1 1 1 1 1/2 1 1 1
lp54 (A) 1 1 1 1 1 1 1 1 1 1
lp56 (Q) 1 1 1 2p 1 1 1 1 1 1
cp32-1 (P) 1 1 1 1 1 1 1 1 1 1
cp32-3 (S) 1 1 1 1 1 1 1 1 1 1
cp32-4 (R) 1 1 1 1 1 1 1 1 1 1
cp32-6 (M) 1 1 2 1 1 2 1 1 1 1
cp32-7 (O) 1 1 1 1 1 1 2 1 1 1
cp32-8 (L) 1 1 1 1 1 1 1 1 1 1
cp32-9 (N) 2 1 2 1 2 2 1 2 2 1
a The presence or absence of each plasmid was determined by PCR. Negative PCR results were confirmed by Southern hybridization. Infectivity data are presented
as the total number of culture-positive mice over the total number tested. The pluses and minuses indicate that product (of the predicted size) was or wasn’t obtained,
respectively; 1/2 implies weak amplification. The asterisks indicates that an amplification product was obtained but differed in size from that predicted by the B.
burgdorferi B31MI genome sequence (15). ND, not determined.
b The letters in parentheses are designations assigned by The Institute for Genomic Research.
TABLE 3. Predicted sizes of the HaeIII restriction fragments
targeted by various probes
Plasmidb Probe Hybridization target size (bp)a
cp32-1 (P) uhb(1) 2,048
cp32-1 (P) BBP 2,301
cp32-2 uhb2(1) 1,863
cp32-3 (S) uhb(1) 7,821
cp32-4 (R) ospF 3,978
cp32-5 uhb(1) ND
cp32-6 (M) uhb(1) 3,360
cp32-7 (O) uhb(1) 2,684
cp32-8 (L) uhb(1) 2,048
cp32-8 (L) BBL 3,744
cp32-9 (N) uhb(1) 3,518
lp56 (Q) uhb(1) 869
a Predicted HaeIII restriction fragment sizes were determined based on the B.
burgdorferi B31MI genome sequence available at http://www.tigr.org. The size of
the uhb(1)-targeted HaeIII restriction fragment derived from plasmid cp32-5
could not be determined (ND), since the sequence of this plasmid is not known.
The size of the fragment derived from cp32-2 was determined based on limited
sequence information available in the databases for this plasmid. As indicated in
the text, neither cp32-2 nor cp32-5 was found to be present in the genome of B.
burgdorferi B31MI.
b The letters in parentheses are designations assigned by The Institute for
Genomic Research.











others lacked cp32-6, cp32-9, and/or cp32-7. The loss of these
plasmids was confirmed through additional hybridization anal-
yses using oligonucleotides targeting other regions of the plas-
mids. For example, the loss of cp32-6 was confirmed using a
probe targeting the BBM38 gene (Fig. 2). In all other cases,
these additional analyses corroborated the absence of these
plasmids from certain clones. In some additional cases, plas-
mid-specific probes were required to ascertain the presence or
absence of specific plasmids. For example, both cp32-8 and
cp32-1 are predicted to yield HaeIII restriction fragments of
2,048 bp that possess binding sites for the uhb(1) probe;
hence, to differentiate between these plasmids, additional
probes were required. A plasmid-specific probe was required
for cp32-4 as well. The BBL, BBP, and ospF-R oligonucleo-
tides are specific for plasmids cp32-8, cp32-1, and cp32-4, re-
spectively. Hybridization analyses revealed that these plasmids
were carried by all clones. The results of the hybridization
analyses are summarized in Table 2.
The linear plasmid lp56 carries an integrated cp32 (9) and is
predicted to yield a uhb(1)-hybridizing HaeIII restriction frag-
ment of 869 bp. An appropriately sized hybridizing restriction
fragment was detected in all clones analyzed (data not shown).
This hybridization band is not visible in Fig. 1, as it was nec-
essary to run it off the gel in order to obtain maximal separa-
tion of other similarly sized UHB-carrying restriction frag-
ments.
Analysis of infectivities of clonal populations derived from
B. burgdorferi B31MIpc that differ in their cp32 plasmid com-
positions. To determine if the observed variation in cp32 com-
position influences the abilities of clonal populations to estab-
lish infection in mice, clones lacking one or more cp32s were
needle inoculated into C3H-HeJ mice. Initial experiments
were performed using an inoculum of 103 spirochetes for the
parental clone and clones 17, 24, and 53. At 1 and 3 months
postinoculation, ear punch biopsy specimens and blood were
recovered and placed in complete BSK-H medium to allow
cultivation of the spirochetes. Positive cultures were obtained
for clones 53 and pc from both the 1- and 3-month time points,
while all other cultures were negative. To allow for the possi-
bility that the kinetics of growth might be slower for some
clones, the cultures were allowed to persist for 2 months. How-
ever, even after this time only clones 53 and pc were culture
positive. The experiment was repeated using three mice per
clone, an inoculum of 107 spirochetes, and a broader range of
clones (clones pc, 9, 14, 24, 29, 36, 37, and 53). At 1 month
postinoculation, positive cultures were obtained for clones pc,
29, 36, 37, and 53 but not clones 9, 14, 17, and 24. At 3 months
postinoculation, the mice were sacrificed, and ear punch biopsy
specimens, blood, spleens, and kidneys were collected. Clones
pc 29, 36, 37, and 53 were culture positive, whereas clones 9,
14, 17, and 24 were culture negative for all tissues tested.
Complete analysis of the plasmid compositions of infectious
and noninfectious clonal populations derived from B. burgdor-
feri B31 MI. To determine if there were additional differences
in the linear- and non-cp32 circular-plasmid profiles in the
infectious and noninfectious clonal isolates described above, a
PCR strategy was employed to test for each plasmid. B. burg-
dorferi B31MIpc and B. burgdorferi MSK5 served as positive
controls to verify that the primers were specific. Amplification
was scored as follows: 2, no amplification; 1/2, weak ampli-
fication; and 1, strong amplification. Weak amplification may
indicate that certain plasmids have been lost from the majority
of the population. Upon PCR, all primer sets yielded ampli-
cons of the expected sizes. Representative PCR results are
shown in Fig. 3, and the data are summarized in Table 2.
Several clones were found to lack one or more different plas-
mids. The plasmids found to be lost from one or more clones
included lp5, lp28-2, lp28-3, cp9, cp32-6, or cp32-9. In addition,
as previously reported, we did not detect plasmids cp32-2 and
cp32-5 in B. burgdorferi B31 MIpc or (not surprisingly) in any
of its clonal derivatives. Several clones were found to have lost
as many as four different plasmids relative to the parental
population.
To confirm the negative PCR results obtained for some
plasmids, Southern hybridization analyses were performed
(the hybridization analyses of the cp32s are described sepa-
rately). For example, using an oligonucleotide specific for
lp28-3 (BBH08) as a probe, we confirmed that the plasmid had
been lost from all postinfection clonal populations (Fig. 4).
FIG. 1. Restriction fragment length polymorphism pattern analysis
of the cp32 family of plasmids. DNA was isolated from each clone,
digested with HaeIII, fractionated by agarose gel electrophoresis,
transferred onto Hybond N membrane by vacuum blotting, and hy-
bridized with the 32P-labeled uhb(1) oligonucleotide as described in
the text. The clones analyzed are indicated above each lane, and the
plasmid from which each hybridizing restriction fragment was derived
is indicated on the right. The migration positions for the size standards
are indicated between the panels. pc indicates DNA from the parental
clone, B31MI.
FIG. 2. Confirmation through Southern hybridization analyses of
the loss of cp32-6 from clones. HaeIII-digested DNA from each clone
(indicated above each lane) was fractionated and blotted as described
in the legend to Fig. 1 and then hybridized with the BBM38- targeting
cp32-6 probe. pc indicates DNA from the parental clone, B31MI.












Several studies have demonstrated that loss of infectivity is
associated with plasmid loss in the Lyme disease spirochetes
(26, 41) and that this is the primary mechanism associated with
the phenomenon. One of the first studies to suggest that such
a correlation exists was conducted by Schwan and colleagues
(26), where the loss of cp7.6 and lp22 was concomitant with the
loss of infectivity. It is unclear if B. burgdorferi B31MI carries
homologs of these plasmids, since the sequences for these
plasmids were not determined. It is likely that cp7.6 is analo-
gous to cp9.0 (13, 15). Analysis of cp9.0 revealed that it does
not appear to encode proteins with homology to proteins
known to participate in virulence. In this report, we demon-
strate that several clones that have lost this plasmid remain
infective. A similar observation has recently been reported by
Purser and Norris and by Labandeira-Rey and Skare (16, 22).
However, the absence of a strict requirement for cp9.0 should
not be interpreted to suggest that cp9.0-encoded proteins are
not potentially important in Borrelia pathogenesis. Most of the
open reading frames present on cp9.0 are actually members of
plasmid-carried paralogous gene families (5, 15), so paralogs
encoded by other plasmids might complement lost functions.
The identification of a homolog of lp22, a second plasmid
linked to virulence by Schwan et al. (26), in B. burgdorferi
B31MI is complicated by the presence of numerous linear
plasmids in this isolate, ranging from 17 to 30 kb. Other linear
plasmids in this size range have also been implicated as nec-
essary for virulence. The loss of lp28.7 coincides with an in-
crease in the 50% infective dose (ID50), (40, 41). This plasmid
is likely a homolog of one of the four lp28s present in the B.
burgdorferi B31MI genome (8). In general, the complete plas-
mid contents of the isolates analyzed in these earlier studies
were largely unknown, making it difficult to interpret the data
and to compare it with the data obtained from other studies
that used different isolates. Hence, while a correlation between
plasmids and infectivity appeared to exist, the specific plasmids
associated with the phenomenon remained elusive.
In this study, we have focused our analyses on clonal popu-
lations derived from B. burgdorferi B31MI. The genome se-
quence for this isolate has recently been determined, allowing
these studies to be conducted with an isolate of known genetic
composition (15). Other recent studies of this topic have also
exploited the genome sequence in their analyses of plasmid
composition and infectivity (16, 22). The studies described
here began with a particular interest in the possible role of the
cp32 plasmid family in infectivity and virulence. Analyses con-
ducted by our laboratory and others have demonstrated that
several of the genes carried by these plasmids are differentially
expressed during infection (1, 12, 36, 39; J. V. McDowell, S.-Y.
Sung, G. Price, and R. T. Marconi, submitted for publication)
and that some may play a role in immune evasion (37). An
initial assessment of cp32 compositions in different B31MI-
derived clones led to the identification of several with differing
cp32 restriction fragment length polymorphism patterns. To
determine if these variants were infective, we employed the
C3H-HeJ mouse model. Initial analyses utilized low inoculat-
ing doses of ;500 spirochetes (intradermal inoculation), and
infectivity was assessed by the ability to cultivate the bacteria
from ear punch biopsy specimens. We found that several of the
clones were not infective. One possibility was that these par-
ticular clones might simply have altered ID50s. To maximize
the potential establishment of infection, we used a high inoc-
ulating dose of ;107 spirochetes. As before, the same results
were obtained for each clone. In addition, cultures of other
tissues and organs from the mice that were culture negative
with the ear punch biopsy specimens were also culture nega-
tive. Hence, the phenomenon that we observed was that the
clones were either infectious or noninfectious. The use of two
different inoculum sizes (500 and 107 spirochetes) that are at
opposite ends of the scale but yielded the same results dem-
onstrates that the molecular events that occurred in these
clones did not simply alter the ID50. It is important to note that
the 107-spirochete inoculating dose had no discernible negative
impact on any of the inoculated mice. In assessing these data,
FIG. 3. Determination of the plasmid compositions of B. burgdor-
feri B31MI clones by using a PCR approach. Isolated genomic DNA
served as a template for PCR analyses using plasmid-specific primer
sets. Amplification products were fractionated on a 1% agarose gel and
stained with ethidium bromide. The gel was then scanned to generate
the figure. All methods were as described in the text. On the left, the
B. burgdorferi B31MI clones analyzed and the migration positions of
the size standards are indicated. The plasmid tested for is indicated
above each lane.











a clear-cut correlation between the loss of any one specific
cp32 and the loss of infectivity was not discernible. Recent
studies conducted by others have reached similar conclusions
(16, 22). From this, we conclude that a complete set of all seven
cp32s is not required for infectivity, maintenance of infection,
or in vitro cultivation. The apparent lack of a requirement for
a complete set of cp32s is consistent with the extensive varia-
tion in composition that has been demonstrated for this plas-
mid family in a wide range of isolates (19, 38). However, in
view of the extensive genetic redundancy among the cp32s, it is
perhaps not surprising that the loss of a subset of these genetic
elements would have miminal impact on infectivity, virulence,
or the ability to grow in vitro, since the proteins encoded by the
multiple cp32s may complement each other. It should be noted
that lp56 also contains an integrated cp32 and could serve to
complement functions lost through the loss of cp32s (8). In-
terestingly, all Lyme disease isolates analyzed, as well as re-
lapsing fever isolates, carry at least some cp32s (6, 7, 19, 23, 24,
34, 38). This observation suggests that maintenance of at least
a subset of these plasmids is a necessary biological feature at
the genus-wide level. It is important to note that the clones
analyzed in this report were only briefly cultivated postinfec-
tion, suggesting that the changes in cp32 plasmids occurred
during infection. Alternatively, the plasmids could have been
lost during the postinfection cultivation period. Several obser-
vations argue against this. We have found that the cp32s of
Borrelia garinii Pbi were retained after 311 in vitro passages
(;4 years of continuous cultivation) (R. T. Marconi, unpub-
lished data). Furthermore, to our knowledge, the loss of cp32s
specifically during in vitro cultivation has not been reported.
Hence, the cp32s may actually be less stable during infection
than they are during in vitro cultivation. Studies by Eggers and
Samuels suggest that the cp32s may actually encode prophage
(14). It is possible that the mammalian environment stimulates
bacteriophage transduction or plasmid transfer during infec-
tion, leading to changes in cp32 composition.
To determine if there might be a correlation between the
loss of other plasmids and infectivity, we determined the com-
plete plasmid compositions of several clones that were found in
the analyses above to be either infectious or noninfectious.
lp28-3 was the only plasmid absent from all noninfectious
clones. lp28 is one of four similarly sized linear plasmids car-
ried by B. burgdorferi B31MI (15). The specific absence of this
plasmid was confirmed by both PCR and Southern hybridiza-
tion. While we initially interpreted these data to suggest a
correlation between Ip28-3 and infectivity, additional analyses
of other infectious clones revealed that some of them also
lacked lp28-3. Analysis of clones lacking this plasmid revealed
that they were infective even when an inoculum of ;500 spi-
rochetes was used. Hence, it is evident that lp28-3 is not strictly
required for infectivity and that its loss does not affect the ID50.
Two of the lp28-3-minus infectious clones also lacked lp28-2.
In a previous analysis, it was demonstrated that the loss of an
;28-kb linear plasmid correlated with an increase in ID50 from
103 to 105 in the hamster model (41). However, in that study it
was not specifically determined which of the four lp28s was
lost. In an analysis of linear plasmids, Palmer et al. demon-
strated that lp28-1, lp28-3, lp28-4, lp36, and lp54 were carried
by all 15 Lyme disease spirochete isolates analyzed. They in-
terpreted this to mean that these plasmids are biologically
necessary (20). However, the data presented here demonstrate
that the loss of lp28-3 and lp28-2 does not abrogate the ability
of B31MI clones to establish and maintain infection. Purser
and Norris also reported that lp28-2 (and lp28-4) is not re-
quired for infectivity (22). In that analysis, the authors did not
test clones lacking lp28-3, since all of the clones in their col-
lection carried the plasmid. It is possible that the decrease in
ID50 reported by Xu et al. resulted from the loss of lp28-1 (41).
Evidence has recently been presented which demonstrates
that the loss of lp25 and lp28-1 is coincident with a low-infec-
tivity phenotype (16, 22). However, none of the noninfectious
clones analyzed as part of our study had lost either of these
plasmids. We do not believe this to represent a discrepancy
between these reports and the data presented here. Specific
plasmids may very well play critical roles in infectivity or vir-
ulence, and the data presented by others suggest that lp25 and
lp28-1 are in this category. What is striking is that in the three
recent reports that have assessed the possible link between
specific plasmids and infectivity, the specific plasmids lost by
the clonal populations differed widely. We found that most of
the clones analyzed in this report had lost lp28-3, while this
plasmid was universally present in the clones analyzed by
Purser and Norris and Labandeira-Rey and Skare. A second
notable difference was in the cp32s. Purser and Norris found
that all of the cp32s, with the exception of cp32-3, which was
lost from only a single clone (B. burgdorferi 5A3), were retained
(note that Labandeira and Skare did not determine the com-
plete composition of the cp32 plasmid family in all clones
analyzed). In contrast, we found that six of the eight clones
derived from B. burgdorferi B31MI pc had lost one or more
cp32s. The data presented here suggest that undefined mech-
anisms independent of the loss of a specific plasmid can also
lead to the loss of infectivity. In addition, it is also evident from
the variation noted in this and other recent studies that the
FIG. 4. Southern hybridization analysis of lp28-3. HaeIII-digested DNA from each clone (indicated above each lane) was fractionated and
blotted as described in the legend to Fig. 1. The blot was hybridized with the lp28-3 targeting probe, BBH08. Molecular standards are indicated
on the left. pc, indicates DNA from the parental clone, B31MI.











dynamics of plasmid loss can vary widely under different ex-
perimental conditions (16, 22).
The central point of the analyses presented here is that the
loss of infectivity does not in all cases correlate with the loss of
a specific plasmid. However, this is not to say that such a
correlation does not exist. It remains possible that there is an
essential plasmid or combination of plasmids that are required
for infectivity and virulence. In view of the genetic redundancy
among the plasmids and thus the potential for complementa-
tion of function, it would seem most likely that this putative
essential plasmid would be one of those that carries genes not
harbored by other elements of the genome so that complemen-
tation could not occur. Perhaps a possible biological role for
the redundancy in the Lyme disease spirochete genome is to
shield the bacteria from the potentially adverse consequences
associated with the inherent instability of its plasmid-based
genome. Studies by others suggest that lp25 and lp28-1 are
possible essential plasmids (16, 22). Nonetheless, even though
certain plasmids may prove essential, the data presented here
demonstrate that other mechanisms independent of plasmid
loss appear to also be at play. These may include small-scale
mutations or rearrangements in essential genes and/or differ-
ences in gene expression patterns among clonal populations.
The analyses presented here provide further insight into the
fluid nature of the Borrelia genome and the mechanisms asso-
ciated with loss of infectivity. Furthermore, this study illus-
trates the complexity of assessing the contribution of the plas-
mid component of the Borrelia genome to the biology and
pathogenesis of the Lyme disease spirochetes.
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